WHO's Covid-19 Origin Report Draws Fire

WHO's Covid-19 Origin Report Draws Fire

Assessment

Interactive Video

Business, Social Studies

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the challenges faced by WHO experts in investigating the origins of COVID-19, highlighting issues with access and differing expectations of the investigation's scope. It also covers the ongoing concerns about the safety of the AstraZeneca vaccine, particularly regarding blood clots, and the resulting restrictions imposed by countries like Canada and Germany. The video emphasizes the difficulty in proving the vaccine's safety and the broader challenge of administering vaccines to healthy individuals to prevent potential future risks.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was one of the main challenges faced by experts investigating the origins of COVID-19 in China?

Inability to access necessary data and sites

Shortage of qualified experts

Political disagreements among countries

Lack of funding for the research

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one theory about the origin of COVID-19 that requires further investigation?

It leaked from a lab in Wuhan

It was spread by contaminated water

It originated from a meteorite

It was created as a biological weapon

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a significant concern regarding the AstraZeneca vaccine?

It causes severe allergic reactions in all recipients

It requires extremely cold storage conditions

It is ineffective against all COVID-19 variants

It may be linked to blood clots in some individuals

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which countries have imposed new restrictions on the AstraZeneca vaccine due to safety concerns?

United States and United Kingdom

Canada and Germany

Australia and New Zealand

India and Brazil

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is it challenging to prove the safety of the AstraZeneca vaccine?

The vaccine has not been tested on a diverse population

There is no data available on its long-term effects

Blood clots occur at low levels and can happen without the vaccine

The vaccine is still in the experimental phase